Last Updated: November 10, 2026

Details for New Drug Application (NDA): 204929

« Back to Dashboard

NDA 204929 describes ZILEUTON, which is a drug marketed by Aizant, Annora Pharma, Lupin, Rising, Strides Pharma Intl, and Teva Pharms Usa, and is included in six NDAs. It is available from five suppliers. Additional details are available on the ZILEUTON profile page.

The generic ingredient in ZILEUTON is zileuton. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the zileuton profile page.

Summary for 204929

Tradename:	ZILEUTON
Applicant:	Rising
Ingredient:	zileuton
Patents:	0

Pharmacology for NDA: 204929

Mechanism of Action	5-Lipoxygenase Inhibitors
Physiological Effect	Decreased Leukotriene Production

Suppliers and Packaging for NDA: 204929

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZILEUTON	zileuton	TABLET, EXTENDED RELEASE;ORAL	204929	ANDA	Rising Pharma Holdings, Inc.	64980-206	64980-206-12	120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	600MG
Approval Date:	Mar 17, 2017	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.